Drivers and barriers in the consistency approach for vaccine batch release testing: Report of an international workshop.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsBruysters, Martijn W P
van der Stappen, Ton
Hessel, Ellen V
Akkermans, Arnoud M
Vandebriel, Rob J
MetadataShow full item record
TitleDrivers and barriers in the consistency approach for vaccine batch release testing: Report of an international workshop.
Published inBiologicals 2017, 48:1-5
PubliekssamenvattingSafety and potency assessment for batch release testing of established vaccines still relies partly on animal tests. An important avenue to move to batch release without animal testing is the consistency approach. This approach is based on thorough characterization of the vaccine, and the principle that the quality of subsequent batches is the consequence of the application of consistent production of batches monitored by a GMP quality system. Efforts to implement the consistency approach are supported by several drivers from industry, government, and research, but there are also several barriers that must be overcome. A workshop entitled "Consistency Approach, Drivers and Barriers" was organized, which aimed to discuss and identify drivers and barriers for the implementation of the 3Rs in the consistency approach from three different perspectives/domains (industry, regulatory and science frameworks). The workshop contributed to a better understanding of these drivers and barriers and resulted in recommendations to improve the overall regulatory processes for the consistency approach. With this report, we summarise the outcome of this workshop and intend to offer a constructive contribution to the international discussion on regulatory acceptance of the consistency approach.
- The consistency approach for quality control of vaccines - a strategy to improve quality control and implement 3Rs.
- Authors: De Mattia F, Chapsal JM, Descamps J, Halder M, Jarrett N, Kross I, Mortiaux F, Ponsar C, Redhead K, McKelvie J, Hendriksen C
- Issue date: 2011 Jan
- Consistency as tool to support in vitro batch potency testing in GMP production.
- Authors: Stirling C
- Issue date: 2012
- Potency testing of veterinary vaccines: the way from in vivo to in vitro.
- Authors: Romberg J, Lang S, Balks E, Kamphuis E, Duchow K, Loos D, Rau H, Motitschke A, Jungbäck C
- Issue date: 2012 Jan
- Modern science for better quality control of medicinal products "Towards global harmonization of 3Rs in biologicals": The report of an EPAA workshop.
- Authors: Schutte K, Szczepanska A, Halder M, Cussler K, Sauer UG, Stirling C, Uhlrich S, Wilk-Zasadna I, John D, Bopst M, Garbe J, Glansbeek HL, Levis R, Serreyn PJ, Smith D, Stickings P
- Issue date: 2017 Jul
- Three Rs potential in the development and quality control of immunobiologicals.
- Authors: Halder M
- Issue date: 2001